MeSH tree: D03.383.742
Mayo Clinic researchers have identified a drug-and-supplement combination therapy that is capable of reducing the harmful effects of senescent cells—also known as "zombie cells"—in diabetic kidney disease. In eBioMedicine, ...
Mar 5, 2026
0
0
A large registry study in Finland by the University of Oulu and the University of Eastern Finland shows that many older adults receive antipsychotic medications for purposes other than those officially approved. Known as ...
Feb 23, 2026
0
0
Researchers at the Ribeirao Preto Blood Center and the Center for Cell-Based Therapy (CTC) conducted a study using the NK-92 cell line to test new models of chimeric antigen receptors (CARs) with specific costimulatory domains, ...
Feb 20, 2026
0
1
A new study in mice hints at the potential to use tiny particles made with RNA molecules to deliver chemotherapy drugs and other therapies directly to tumors, killing cancer cells without generating an immune response or ...
Feb 6, 2026
0
117
For many cancer patients, hair loss is one of the most distressing side effects of their therapy. Increasingly, they have been taking oral supplements of biotin, which are marketed to consumers for their potential to improve ...
Jan 20, 2026
0
0
Bowel habits aren't exactly dinner-table talk. But they reflect how quickly the gut moves things along, and when that goes wrong, people can experience constipation, diarrhea, or irritable bowel syndrome (IBS). Yet the biological ...
Jan 20, 2026
0
269
Many seniors with dementia are being put at risk by brain-altering medications linked to falls, confusion and hospitalization, a new study says.
Jan 17, 2026
0
1
Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United States who received the injectable intramuscular antiviral medications cabotegravir and rilpivirine for nearly ...
Jan 15, 2026
0
0
A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women facing platinum-resistant ovarian cancer (PROC). Researchers evaluated a novel DNA-based therapy, Elenagen, ...
Jan 12, 2026
0
0
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common frontline therapies.
Dec 29, 2025
0
97
